Patients with A1C greater than 9% are at risk of life-threatening severe hyperglycemia and outcomes such as retinopathy, neuropathy, and diabetic ulcers
Thus, a critical appreciation of these inherent limitations at each stagefrom cell culture to animal modelsis paramount for rigorously interpreting data and designing studies with genuine clinical relevance
In contrast, PG-102 achieved a ~450 mg/dL glucose reduction and ~5% HbA1c decrease by 2-months, restoring normoglycemia and maintaining efficacy throughout the 3-month study (Fig
Multi-Nutrient Formula B12, B complex, vitamin C, zinc, magnesium, glutathione delivered intravenously 100% Bioavailability Direct bloodstream delivery bypasses digestive absorption limitations Therapeutic Dosing Higher concentrations than possible with oral vitamins and supplements Synergistic Benefits Combined nutrients work together for enhanced effectiveness RN-Only Administration Process Every Renew IV is administered by a registered nurse following standard medical protocols for IV insertion and monitoring
